AF recurrence was assessed using several surrogate markers, such as hospitalizations and procedures, which may underestimate true recurrence rates based on a systematic analysis of ECG by an adjudication committee, which was not possible considering the structure of the analysis
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications with specific UK licences: some are approved for type 2 diabetes management (semaglutide [Ozempic], dulaglutide [Trulicity], liraglutide [Victoza]), while others are specifically licensed for weight management in adults with obesity or overweight with weight-related comorbidities (semaglutide [Wegovy], liraglutide [Saxenda])
Get a clear sense of how your body responds to it before introducing additional compounds
From a side effect standpoint, the peptides may cause mild water retention or tingling in some users initially, but these effects are typically transient
its usually short-lived and manageable